WO2024121816 - SAMPLE-TESTING SYSTEM FOR MEASURING PROPERTIES OF RED BLOOD CELLS
National phase entry:
Publication Number
WO/2024/121816
Publication Date
13.06.2024
International Application No.
PCT/IB2023/062425
International Filing Date
08.12.2023
Title **
[English]
SAMPLE-TESTING SYSTEM FOR MEASURING PROPERTIES OF RED BLOOD CELLS
[French]
SYSTÈME DE TEST D'ÉCHANTILLON POUR MESURER DES PROPRIÉTÉS DE GLOBULES ROUGES
Applicants **
ORANGE BIOMED CO., LTD.
Inventors
KO, Ung Hyeon
PARK, Eun Young
KANG, Seung Jin
Priority Data
63/386,887
09.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2556 | |
| EPO | Filing, Examination, Granting | 15329 | |
| Japan | Filing, Examination, Granting | 2325 | |
| South Korea | Filing, Examination, Granting | 1874 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
28,624
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to systems, devices and methods for measuring analyte levels. A glycated hemoglobin level measuring system includes a sample-testing cartridge having a microchannel that passively transfers and compresses cells. The system can perform one or more calibration or normalization routines on sensor data to generate calibrated or normalized data. The calibrated or normalized data can be used to determine one or more analyte levels.[French]
La présente invention concerne des systèmes, des dispositifs et des procédés permettant la mesure de niveaux d'analyte. Un système de mesure de niveau d'hémoglobine glyquée comprend une cartouche de test d'échantillon ayant un microcanal qui comprime et transfère passivement des cellules. Le système peut effectuer une ou plusieurs routines d'étalonnage ou de normalisation sur des données de capteur pour générer des données étalonnées ou normalisées. Les données étalonnées ou normalisées peuvent être utilisées pour déterminer un ou plusieurs niveaux d'analyte.